Blood Banking II Flashcards
Special antigens
1 Bombay antigen
2 Australia antigen
Terminal carbohydrates of RBC
Fucose
Galactose
Subtypes
O > A1 > B > A2 > AB
Most basic surface antigen
H antigen
Has H-antigen only
Blood type O
Discovered that blood clumping is an immunological reaction
Karl Landsteiner
A antigen
H-antigen + N acetyl-galactosamine
Phenotype and genotype representations in the ABO blood typing system
(Review)
B antigen
H-antigen + another galactose
Located on the surface of RBCs
Antigens
ABO gene locus
Chromosome 9
No H antigen
Bombay antigen
Discovered Australia antigen
Baruch Blumberg
Causes susceptibility to certain diseases such as infectious mononucleosis and hepatitis infection
Australia antigen
T or F. ABO gene is autosomal
T
Co-dominant groups
A and B
Located in the blood plasma
Antibodies
Other term for reverse ABO screening
Antibody screening
Universal donor
O+
Location of Fy locus
Near the centromere on the long arm of chromosome 1 (syntenic to Rh which is located near the tip of the short arm)
Rh+
RBCs carry the Rh or D antigen
If a person inherited one group A gene and one group B gene, his RBC would possess both the A and B blood group antigens
Co-dominance
Rh Nomenclature
1 Fisher-Race Classification (C, E, D minor subtypes)
2 Weiner Classification
Weakly reacting D antigens
Du
Hemolytic anemia in fetus or neonate, caused by transplacental transmission of maternal antibodies to fetal RBCs
Erythroblastosis fetalis
Signs of erythroblastosis fetalis in the neonate
1 Pallor
2 Hepatosplenomegaly
3 Jaundice
Results from incompatibility between maternal and fetal Rh antigens
Erythroblastosis fetalis
Difference of M and N
Amino acid sequence at positions 1 and 5
Signifies active hemolysis in the neonate
Hepatosplenomegaly
AB-
Universal recipient
Easily destroyed by routine blood bank proteolytic enzymes (ficin, papain, and bromelin) because of their location
M and N
Surface antigens
1 H antigen
2 A antigen
3 B antigen
Signs of erythroblastosis fetalis in the mother
Polyhydramnions
Major RBC sialic acid-rich glycoprotein
Glycophorin A
Amino acid sequence of M
Serine (1)
Glycine (5)
Transmembrane proteins with loops exposed on the surface of RBCs
Rh antigens
A protein that carries many antigens
Glyocophorin
Difference of S and s
Amino acids at position 29 on Glycophorin B
Less easily degraded by enzymes because antigens are located farther down the glycoprotein
S and s
Amino acid at position 29 of s
Threonine
Detected on renal capillary endothelium and epithelium
M, N, S
Gene coding for GPB
GYPB
Amino acid sequence of N
Leucine (1) Glutamic acid (5)
Not synthesized by RBCs; only adsorbed from plasma
Lewis antigens
Amino acid at position 29 of S
Methionine
Reagent: red cells
Reverse ABO typing
Duffy antigens
Fya and Fyb
Lewis antigens in secretions
Glycoproteins
Characteristics of Duffy antigens
1 Destroyed by proteolytic enzymes (ficin, papain, bromelin), chymotrypsin, ZZAP
2 Do not bind complement
3 Stimulated by transfusion or pregnancy
4 Do not react with enzyme-treated RBCs
Found on brain, colon, endothelium, lung, spleen, thyroid, thymus, and kidney cells
Duffy antigens
M and N:
S and s:
Outer end of Glycophorin A
Glycophorin B
Not found on platelets, lymphocytes, monocytes or granulocytes
M, N, S, Duffy antigens
Similar to Rh system
Kell system
Location of genes GYPA and GYPB
Chromosome 4
Destroy Kell antigens
1 Trypsin and chymotrypsin 2 Dithiothreitol (DTT) 3 ZZAP (a combination of DTT and papain or ficin) 4 Glycine-acid-EDTA
Lewis antigens in plasma and on RBCs
Glycolipids
Other term for k
Cellano
Immunogenic in stimulating antibody production
Kell antigens
Most immunogenic in stimulating antibody production
D antigen
For ABO grouping
Direct antiglobulin test
Other term for K
Kell
Blood typing laboratory techniques
1 Slide method and tube method
2 Gel method
Reverse typing
Patient serum + known RBC
Implicated in severe hemolytic transfusion reactions and HDN
Kell antigens
Associated with chronic granulomatous disease
McLeod syndrome
Blood typing results interpretation
(Review)
Antisera
1 Anti-A (blue)
2 Anti-B (yellow)
3 Anti-Rh/D (colorless, transparent)
Detects antibodies
Reverse typing
Reverse grouping test procedure
1 Label card with PID and remove foil
2 Add 50 mcl of each 0.8% reagent red cell suspension to a microtube (A1, A2, B cells)
3 Add 50 mcl of serum or plasma to each microtube
4 Spin card in ID centrifuge
5 Interpret results
Gel method tests
1 Forward antigen typing
2 Reverse ABO typing/Antibody screening
Forward antigen typing procedure
1 Prepare 5% cell suspension in Diluent 1 (Bromelin) 500 mcl diluent + 50 mcl blood or 25 mcl cell concentrate
2 Incubate at room temperature for 10 minutes
3 Label card with PID and remove foil
4 Add 10 mcl of cell suspension to each microtube
5 Spin card in ID centrifuge
6 Interpret results
Test for serum
Antibody screening
T or F. A and O blood groups are dominant over B.
F. A and B blood groups are dominant over O.
Represents a tissue group
Lewis system
Forward typing
Patient RBC + known antisera
Gene coding for GPA
GYPA
Indications for ABO grouping
1 Blood donors 2 Transfusion recipients 3 Transplant candidates and donors 4 Prenatal patients 5 Newborns 6 Paternity testing
Uses human polyclonal antisera
Direct antiglobulin test
Detects RBC surface antigen
Forward typing
The most important and frequently performed procedure in the routine blood bank
Cross-matching
Determines compatibility between patient serum and donor red blood cells
Type and cross
Functions of cross-matching
1 Determines compatibility of donor’s blood with recipient’s blood
2 Identifies matches for organ transplants
3 Detects clinically significant antibodies
Two categories of cross-matching
1 Major
2 Minor
Three types of cross-matching
1 Full
2 Immediate spin
3 Electronic
Tests if the recipient has any antibodies to the antigens of the donor’s cells
Major cross-matching
Major cross-matching
Recipient serum is tested against donor packed cells
Minor cross-matching
Recipient red cells are tested against donor serum
Detects donor antibodies directed against a patient’s antigens
Minor cross-matching
Safest and most comprehensive type of cross-matching
Full cross-matching
Identifies that an agglutination reaction is caused by IgM rather than IgG or complement activation
Immediate spin cross-matching
Last guard to ensure a safe transfusion
Electronic cross-matching
Includes ABO/Rh typing of the unit and of the recipient, and an antibody screen of the recipient
Electronic cross-matching
Requirement of electronic cross-matching
Patient: negative antibody screen
Negative antibody screen
1 No active RBC atypical antibodies
2 RBC atypical antibodies below the detectable level of current testing methods
Three methods of cross-matching
1 Saline method (slide and tube)
2 Albumin tube
3 Coomb’s test
Detects the presence of expected antibodies
ABO system
Detects the presence of unexpected antibodies
Antibody screening
Unexpected antibodies
1 Immune alloantibodies
2 Pollen
3 Fungus
4 Bacteria
Clinically significant antibodies known to cause transfusion reactions and HDN
1 Anti-A
2 Anti-B
3 IgG (react at 37 Celsius or in the antihuman globulin phase of the indirect antiglobulin test)
Alloantibodies
Antibodies to an antigen which an individual lacks
Autoantibodies
Antibodies to an antigen that a person has
Antibody screening methods
1 Tube method
2 Column agglutination
3 Solid phase interference
Tube method procedure
1 Add one drop of reagent to 2 drops of patient serum
2 Mixture is centrifuged and observed for agglutination or hemolysis at room temperature
3 Enhancement media is aded and the tubes are incubated at 37 Celsius
4 After incubation, antihuman globulin antisera is added and the tube is centrifuged and read
5 Agglutination and hemolysis mean antigen and its corresponding antibody are present
6 Antigram is consulted
7 Large panel of RBCs representing multiple donors can be tested with the recipient’s RBCs
Used to determine preliminary identity in tube method of compatibility testing
Antigram
Listing of identified antigens present on the RBCs in each vial representing one donor
Antigram
Column agglutination procedure
1 Precisely measured volumes of screening reagent RBCs (0.8% suspension in LISS) and plasma are incubated at 37 Celsius in the reaction chamber above the column matrix
2 Following incubation, plastic cards are centrifuged under carefully controlled conditions
3 IgG-coated RBCs agglutinate as they come in contact with the AHG reagent in the matrix and are trapped
4 Unagglutinated RBCs pass through easily and are found as pellet at the bottom
Principles of solid-phase interference
(Review)
Solid-phase interference procedure
1 Reagent RBCs are bound to the bottom of microplate wells. Serum and an enhancement reagent are added and incubated at 37 Celsius.
2 After washing to remove unbound serum globulins, indicator RBCs coated with AHG are added, and the plates are centrifuged
3 Interpret results
Negative reaction in solid-phase interference
Discrete button on the bottom of the well
Positive reaction in solid-phase interference
Antiglobulin coated indicator cells bind and cover the bottom surface of the well